Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
Open Access
- 16 September 2011
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 25 (1) , 13-18
Abstract
The aim of this study was to evaluate the relationship of local intrarenal renin angiotensin system (RAS) with hypertension and proteinuria in renal transplant recipients. Sixty-nine nondiabetic renal transplant recipients (39 male, mean age: 36.3 ± 11.5 years) were included in this study. All patients were in stable condition with GFR greater than 30 ml/min/1.73 m2; (MDRD). Hypertension was defined to be present if there was a recorded diagnosis of hypertension, systolic blood pressure >130 mmHg and/or diastolic blood pressure >80 mmHg according to ambulatory blood pressure monitoring. None of the hypertensive patients were receiving RAS blockers. Spot urine samples were obtained to measure urinary angiotensinogen (AGT) using human AGT-ELISA, urinary creatinine and protein levels. The demographic properties and laboratory findings were similar between hypertensive and normotensive transplant recipients. Urinary AGT–creatinine ratio (UAGT/UCre) was significantly higher in hypertensive patients compared with the normotensives (8.98 ± 6.89 μg/g vs. 5.48 ± 3.33 μg/g; P = 0.037). Importantly, a significantly positive correlation was found between UAGT/Ucre levels and proteinuria in hypertensive patients (P = 0.01, r = 0.405). Local intrarenal RAS probably plays an important role in the development of hypertension and proteinuria in renal transplant recipients.Keywords
This publication has 31 references indexed in Scilit:
- Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathyNephrology Dialysis Transplantation, 2010
- Increased Urinary Angiotensinogen Is Precedent to Increased Urinary Albumin in Patients With Type 1 DiabetesThe American Journal of the Medical Sciences, 2009
- Urinary Angiotensinogen as a Novel Biomarker of the Intrarenal Renin-Angiotensin System Status in Hypertensive PatientsHypertension, 2009
- The importance of the intrarenal renin–angiotensin systemNature Clinical Practice Nephrology, 2008
- Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseasesJournal of the American Society of Hypertension, 2008
- Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathyJournal of the Renin-Angiotensin-Aldosterone System, 2008
- The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney DiseasePharmacological Reviews, 2007
- Urinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity Associated with Deterioration of Renal Function in Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2007
- Enhanced Intrarenal Angiotensinogen Contributes to Early Renal Injury in Spontaneously Hypertensive RatsJournal of the American Society of Nephrology, 2005
- Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytesExperimental & Molecular Medicine, 2004